Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
BACKGROUND: Antidepressants exhibit a variety of pharmacological actions including inhibition of the serotonin and noradrenaline transporters. We wished to investigate whether genetic variation could be used to target or personalise treatment, in a comparison of selective serotonin reuptake inhibito...
Asıl Yazarlar: | Lewis, G, Mulligan, J, Wiles, N, Cowen, P, Craddock, N, Ikeda, M, Grozeva, D, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Peters, T |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2011
|
Benzer Materyaller
-
Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
Yazar:: Wiles, N, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Yazar:: Crawford, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
Yazar:: Crawford, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
Yazar:: Thomas, L, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
Yazar:: O'Donovan Michael, ve diğerleri
Baskı/Yayın Bilgisi: (2008-05-01)